Ubon Competitors

Stocks . Thailand . 
Stock . Ubon Bio Ethanol
UBE Stock   0.47  0.01  2.08%   
Ubon Bio Ethanol competes with Asian Phytoceuticals, United Palm, Chumporn Palm, Do Day, and Bangkok Ranch; as well as few others. Analyzing Ubon Bio competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Ubon Bio to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Ubon Bio Correlation with its peers.

Ubon Bio vs Tropical Canning Correlation

Poor diversification

The correlation between Ubon Bio Ethanol and TC is 0.69 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ubon Bio Ethanol and TC in the same portfolio, assuming nothing else is changed.
Hype
Prediction
LowEstimatedHigh
0.020.472.40
Details
Intrinsic
Valuation
LowRealHigh
0.020.392.32
Details
Naive
Forecast
LowNextHigh
0.010.482.41
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.130.460.49
Details

Ubon Bio Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Ubon Bio and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Ubon and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Ubon Bio Ethanol does not affect the price movement of the other competitor.

High positive correlations

TC
+ 0.81
BR
CPI
+ 0.76
UPOIC
PQS
+ 0.63
APCO
BR
+ 0.63
CPI
TC
+ 0.63
PQS
PQS
+ 0.62
SNPS
  

High negative correlations

TNR
- 0.62
CPI
UPOIC
- 0.56
APCO
TNR
- 0.45
UPOIC
CPI
- 0.39
APCO
TNR
- 0.33
BR
SNPS
- 0.27
UPOIC

Risk-Adjusted Indicators

There is a big difference between Ubon Stock performing well and Ubon Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ubon Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Ubon Bio Competitive Analysis

The better you understand Ubon Bio competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Ubon Bio's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Ubon Bio's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
UBE APCO UPOIC CPI DDD BR SNPS TNR PQS TC
 2.08 
 0.47 
Ubon
 1.44 
 2.82 
Asian
 0.76 
 6.65 
United
 1.16 
 3.48 
Chumporn
 0.78 
 6.45 
DDD
 0.59 
 1.70 
Bangkok
 0.42 
 4.70 
Specialty
 1.79 
 5.50 
Thai
 1.25 
 1.58 
Premier
 2.88 
 5.35 
Tropical
Market Volatility
(90 Days Market Risk)
Extremely Dangerous
Somewhat reliable
Somewhat reliable
Not too volatile
Somewhat reliable
Somewhat reliable
Somewhat reliable
Not too volatile
Risky
Not too volatile
Market Performance
(90 Days Performance)
Mild
Weakest
Soft
Good
Fair
Mild
Weakest
Weakest
Weakest
Fair
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Low
Low
Low
Moderate
Unknown
Small
Unknown
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Over Valued
Under Valued
Over Valued
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Hold
Strong Sell
Strong Buy
Strong Sell
Hold
Sell
Cautious Hold
Strong Sell
Hold
Current Ratio
N/A
4.89
1.43
0.55
13.7
N/A
N/A
1.66
N/A
3.85
Net Asset
7.23 B
680.53 M
1.77 B
4.4 B
5.22 B
10.79 B
N/A
1.6 B
N/A
3.06 B
Profit Margin
0.0419
0.31
0.12
0.0459
0.083
0.0317
N/A
-0.16
N/A
0.079
EBITDA
872.9 M
113.31 M
400.1 M
519.63 M
199.47 M
455.32 M
N/A
(428.82 M)
N/A
288.86 M
Operating Margin
0.0616
0.35
0.15
0.0564
0.12
0.0667
N/A
-0.0258
N/A
0.0698
Current Valuation
6.32 B
2.71 B
2.21 B
3.51 B
1.83 B
7.44 B
N/A
3.93 B
N/A
4.29 B
Price To Book
1.01
5.01
1.47
0.81
1.05
0.62
N/A
3.82
N/A
1.68
Retained Earnings
N/A
104 M
511 M
275 M
N/A
N/A
N/A
N/A
N/A
N/A
Current Asset
N/A
433 M
387 M
1.05 B
N/A
N/A
N/A
N/A
N/A
N/A
Five Year Return
N/A
3.34
2.11
1.84
N/A
N/A
N/A
N/A
N/A
3.32
Beta
N/A
0.35
0.61
0.65
1.21
0.91
N/A
0.82
N/A
0.45
Number Of Employees
N/A
20
17
39
13
8
N/A
19
N/A
19
Shares Outstanding
3.91 B
600 M
324.05 M
632.75 M
317.89 M
913.45 M
N/A
300 M
N/A
330 M
Cash Flow From Operations
783.49 M
84.4 M
89.34 M
324.77 M
(262.76 M)
500.33 M
N/A
70.7 M
N/A
215.71 M
Annual Yield
0.0151
0.0226
0.0741
0.0625
0.0193
0.0917
N/A
0.018
N/A
0.0126
Total Debt
749.88 M
43.19 M
63.33 M
266.32 M
56.39 M
2.4 B
N/A
381.18 M
N/A
23.59 M
Return On Equity
0.0517
0.13
0.25
0.15
0.038
0.0648
N/A
-0.29
N/A
0.2
Z Score
4.8
45.0
21.4
5.2
60.6
0.6
N/A
5.8
N/A
98.8
Return On Asset
0.0351
0.08
0.14
0.0589
0.0257
0.0327
N/A
-0.0162
N/A
0.0831
Book Value Per Share
1.49
0.96
4.45
3.71
14.54
4.7
N/A
3.09
N/A
7.51
Current Liabilities
N/A
42 M
499 M
1.25 B
N/A
N/A
N/A
N/A
N/A
N/A
Total Asset
7.23 B
680.53 M
1.77 B
4.4 B
5.22 B
10.79 B
N/A
1.6 B
N/A
3.06 B
Target Price
2.5
N/A
N/A
N/A
18.88
4.99
N/A
24.5
N/A
16.3
Debt To Equity
N/A
0.077
0.3
128.2
0.011
N/A
N/A
31.9
N/A
0.011
Last Dividend Paid
N/A
0.12
0.5
0.19
0.35
N/A
N/A
0.2
N/A
0.15
Shares Owned By Institutions
0.36
N/A
N/A
4.82
0.04
7.68
N/A
4.0
N/A
0.34
Market Capitalization
6.22 B
3.27 B
2.19 B
1.92 B
5.72 B
2.67 B
N/A
3.42 B
N/A
3.86 B
Price To Earning
N/A
50.0
14.29
65.91
13.1
N/A
N/A
11.27
N/A
8.25
Price To Sales
0.82
11.94
0.77
0.26
2.68
0.31
N/A
1.81
N/A
0.69
Net Income
320.88 M
68.7 M
306.81 M
292.26 M
81.32 M
(55.83 M)
N/A
(464.84 M)
N/A
153.7 M
Earnings Per Share
0.08
0.12
1.04
0.53
0.45
0.29
N/A
-1.55
N/A
1.41
Shares Owned By Insiders
60.2
76.87
87.1
45.46
77.55
39.54
N/A
77.9
N/A
63.96
Revenue
6.97 B
223.35 M
2.07 B
5.6 B
1.41 B
7.26 B
N/A
1.65 B
N/A
4.32 B
Working Capital
N/A
391 M
(112 M)
(203 M)
N/A
N/A
N/A
N/A
N/A
N/A
Cash And Equivalents
N/A
146.48 M
35.17 M
121.58 M
3.46 B
N/A
N/A
64.11 M
N/A
201.75 M
Cash Per Share
N/A
0.24
0.11
0.19
10.89
N/A
N/A
0.21
N/A
0.61
Gross Profit
1.04 B
177.09 M
449.73 M
695.01 M
858.04 M
1.15 B
N/A
340.72 M
N/A
422.93 M
Day Typical Price
0.47
2.8
6.62
3.47
6.33
1.7
4.69
5.5
1.58
5.3
Accumulation Distribution
19640.45
0.0213
160.93
2972.43
1654.68
2766.08
0.0043
24957.18
4717.5
33936.45
Market Facilitation Index
N/A
0.06
0.0
N/A
0.0
N/A
0.02
N/A
N/A
N/A
Daily Balance Of Power
(1.00)
0.6667
0.5
1.0
0.1111
1.0
(1.00)
(0.50)
(0.67)
1.0
Period Momentum Indicator
(0.01)
0.04
0.05
0.04
0.05
0.01
(0.02)
(0.10)
(0.02)
0.15
Rate Of Daily Change
0.98
1.01
1.01
1.01
1.01
1.01
1.0
0.98
0.99
1.03
Day Median Price
0.47
2.79
6.6
3.46
6.28
1.71
4.69
5.5
1.59
5.28
Price Action Indicator
N/A
0.05
0.075
0.04
0.2
N/A
N/A
(0.05)
(0.01)
0.15
Relative Strength Index
62.77
49.6
57.44
59.18
53.72
56.37
63.01
34.39
48.86
67.23
Coefficient Of Variation
1504.41
(2,438)
1915.04
581.79
1056.41
1168.8
18888.02
(1,293)
(2,852)
758.31
Mean Deviation
1.31
0.6284
1.03
0.5952
1.22
0.3818
0.6549
1.04
1.02
0.7339
Jensen Alpha
0.1251
(0.05)
0.0717
0.1249
0.1846
0.016
(0.02)
(0.14)
(0.04)
0.0825
Total Risk Alpha
(0.11)
(0.16)
(0.10)
0.0311
(0.06)
(0.03)
(0.13)
(0.28)
(0.27)
0.0025
Sortino Ratio
0.0097
N/A
(0.02)
0.0305
0.0364
(0.07)
(0.07)
N/A
N/A
0.0249
Downside Variance
7.85
N/A
1.99
1.06
4.7
0.4734
2.05
N/A
N/A
0.8405
Standard Deviation
1.93
0.9297
1.41
0.7704
1.9
0.6024
1.08
1.39
1.71
0.9391
Kurtosis
0.4576
1.17
1.13
(0.15)
4.59
4.09
3.83
1.29
7.44
0.3547
Potential Upside
2.38
1.44
2.31
1.19
3.57
1.2
1.34
1.77
2.61
1.92
Treynor Ratio
(1.58)
2.43
(0.71)
(4.55)
(1.07)
0.1483
(0.03)
(0.52)
0.1847
0.331
Maximum Drawdown
9.21
4.93
6.82
3.54
10.51
3.64
5.48
6.28
10.1
3.94
Variance
3.72
0.8643
1.98
0.5935
3.62
0.3629
1.16
1.93
2.91
0.8818
Market Risk Adjusted Performance
(1.57)
2.44
(0.70)
(4.54)
(1.06)
0.1583
(0.02)
(0.51)
0.1947
0.341
Risk Adjusted Performance
0.0571
(0.03)
0.0446
0.132
0.0786
0.0629
0.0069
(0.05)
(0.02)
0.1031
Skewness
0.143
0.6432
0.8052
(0.12)
0.5973
1.44
(0.06)
0.3491
2.03
0.4701
Semi Deviation
1.42
N/A
0.9725
0.4963
1.43
0.2848
0.9192
N/A
N/A
0.6139
Information Ratio
0.0141
(0.15)
(0.02)
0.0407
0.0415
(0.08)
(0.09)
(0.15)
(0.09)
0.0243
Value At Risk
(2.33)
(1.40)
(2.17)
(1.17)
(2.75)
(0.61)
(1.79)
(1.74)
(2.03)
(0.99)
Expected Short fall
(2.75)
N/A
(1.78)
(0.91)
(1.79)
(0.93)
(1.10)
N/A
N/A
(1.04)
Downside Deviation
2.8
N/A
1.41
1.03
2.17
0.6881
1.43
N/A
N/A
0.9168
Semi Variance
2.01
N/A
0.9457
0.2463
2.05
0.0811
0.845
N/A
N/A
0.3769

Ubon Bio Competition Performance Charts

Five steps to successful analysis of Ubon Bio Competition

Ubon Bio's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Ubon Bio Ethanol in relation to its competition. Ubon Bio's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Ubon Bio in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Ubon Bio's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Ubon Bio Ethanol, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Ubon Bio position

In addition to having Ubon Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run World Allocation Funds Thematic Idea Now

World Allocation Funds
World Allocation Funds Theme
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Ubon Stock

Ubon Bio financial ratios help investors to determine whether Ubon Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ubon with respect to the benefits of owning Ubon Bio security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY